A detailed history of Aquatic Capital Management LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Aquatic Capital Management LLC holds 6,500 shares of SWTX stock, worth $231,335. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,500
Previous 13,200 50.76%
Holding current value
$231,335
Previous $497,000 58.15%
% of portfolio
0.01%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$32.04 - $42.76 $214,668 - $286,492
-6,700 Reduced 50.76%
6,500 $208,000
Q2 2024

Aug 14, 2024

BUY
$36.06 - $47.62 $389,448 - $514,296
10,800 Added 450.0%
13,200 $497,000
Q1 2024

May 15, 2024

BUY
$36.5 - $52.5 $65,700 - $94,500
1,800 Added 300.0%
2,400 $118,000
Q4 2023

Feb 14, 2024

BUY
$18.94 - $37.24 $11,364 - $22,344
600 New
600 $22,000
Q1 2023

May 15, 2023

BUY
$24.97 - $34.05 $4,994 - $6,809
200 New
200 $5,000

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.22B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.